Pharmacology, Toxicology and Pharmaceutical Science
Dabigatran
100%
Anticoagulant Agent
78%
Rivaroxaban
63%
Thromboplastin
61%
Heparin
60%
Apixaban
51%
Antivitamin K
47%
Dabigatran Etexilate
44%
Paroxysmal Nocturnal Hemoglobinuria
44%
Atrial Fibrillation
43%
Prothrombin
43%
Reagent
42%
Thromboembolism
41%
Direct Oral Anticoagulant
33%
Viper Venom
32%
Bleeding
30%
Thrombin
29%
Daboia russellii
29%
Clinical Study
29%
Low Molecular Weight Heparin
28%
Diseases
25%
Drug
24%
Toxic Injury
22%
Thrombosis
21%
Thrombin Inhibitor
20%
Ensure
20%
Pathophysiology
17%
Eculizumab
17%
Drug Concentration
17%
Fibrinogen
16%
Clotting Time
16%
Blood Clotting Factor 10a Inhibitor
16%
Pharmacodynamics
14%
Tissue Factor Pathway Inhibitor
14%
Edoxaban
14%
Betrixaban
14%
Acute Leukemia
14%
Disseminated Intravascular Clotting
14%
Drug Interaction
14%
Inflammation
14%
Cohort Study
14%
Coronavirinae
14%
Crohn Disease
14%
Azathioprine
14%
Vitamin B12
14%
Procoagulant
14%
Recombinant Thromboplastin
13%
Warfarin
13%
Antithrombin
12%
D Dimer
11%
Medicine and Dentistry
Assay
71%
Laboratory
54%
Patient
54%
Coagulation
46%
Procoagulant
42%
Monitoring
40%
Heparin
39%
Blood Stasis
35%
Therapeutic Procedure
33%
Diagnosis
31%
Thrombosis
31%
COVID-19
29%
Membrane Microparticle
29%
Erythrocyte Concentrate
29%
Paroxysmal Nocturnal Hemoglobinuria
29%
Apixaban
29%
Assessment
29%
Acute Leukemia
27%
Thromboplastin
26%
Pathophysiology
20%
Partial Thromboplastin Time
20%
Inpatient
19%
Disseminated Intravascular Coagulation
18%
Plasma
18%
Anticoagulation
18%
Myelodysplastic Syndrome
17%
Thrombin
17%
Heparin-Induced Thrombocytopenia
16%
Platelet
16%
Reagent
15%
Clonidine
14%
Alpha 2 Adrenergic Receptor Stimulating Agent
14%
Edoxaban
14%
Betrixaban
14%
Biological Marker
14%
Microparticle
14%
Coagulopathy
14%
Rivaroxaban
14%
Blood
14%
Patient with Crohn's Disease
14%
Sinus Surgery
14%
Volunteer
14%
Cells
14%
Dabigatran
14%
Neutrophil
14%
Platelet Microparticle
14%
Neoplasm
14%
Ex Vivo
14%
Combination Therapy
14%
Prothrombin Time
14%
Biochemistry, Genetics and Molecular Biology
Coagulation
58%
Prothrombin Time
47%
Thrombin
46%
Hemostasis
45%
Partial Thromboplastin Time
43%
Rivaroxaban
37%
Anticoagulation
36%
Blood Level
36%
Sample
35%
Thrombin Time
31%
Platelet
29%
Time
29%
Antithrombin
22%
D-Dimer
19%
Impedance
17%
Tissue Factor Pathway Inhibitor
14%
Hirudin
14%
Spherocytosis
14%
Disseminated Intravascular Coagulation
14%
Immune Response
14%
Thrombocyte Activation
14%
Acquired Disorder
14%
Quality Control
14%
Thrombocyte Function
14%
Normal Human
14%
Coronavirinae
14%
Tandem Mass Spectrometry
14%
Thromboplastin
14%
Solution and Solubility
14%
Taxonomy
14%
Liquid Chromatography Mass Spectrometry
14%
Dilute Russell's Viper Venom Time
14%
Atrial Fibrillation
14%
Fibrinogen
14%
Reticulocyte
13%
Heparin
11%
Laboratory Test
11%
Viperinae
9%
Dose
9%
Vitamin K
8%
Platelet Count
7%
Platelet-Poor Plasma
6%
Tissue Factor
6%
Screening Test
6%
Scanning Electron Microscopy
5%
Electric Potential
5%
Drug Dose Regimen
5%
Liquid
5%